Pharma and Wall Street saw a future blockbuster. How did a new class of potent, innovative heart drugs turn into such a flop?
Great case study in the consequences of the U.S. health system's incentive problems from @rileyraygriffinhttps://www.bloomberg.com/news/articles/2020-01-09/these-big-drug-flops-show-how-healthcare-economics-have-changed …
0 replies
18 proslijeđenih tweetova
30 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.